June 28, 2019 Clinical Research/Diagn. PR/Corporate

Quanterix Announces Kevin Hrusovsky, Chairman and Chief Executive Officer, and Founder of Powering Precision Health, as EY Entrepreneur of the Year 2019 Award Winner in New England

JUNE 28, 2019 June 28, 2019 12:15 PM Eastern Daylight Time BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that Kevin Hrusovsky, Chairman and CEO of Quanterix, and Founder of Powering Precision Health (PPH), has been recognized with the Entrepreneur Of The... Read more

June 27, 2019 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

IDT signs strategic partnership with Chinese medical sequencing firm ChosenMed

Jun 27, 2019 Partnership strengthens IDT’s position as an NGS leader in China CORALVILLE, IA (June 27, 2019) – Integrated DNA Technologies (IDT) announces that is has entered into a strategic cooperation with ChosenMed Technology (Beijing) Co., Ltd (ChosenMed), a medical sequencing firm focused on personalized medicine and transformation healthcare in China. As part of the collaboration, IDT... Read more

June 27, 2019 Clinical Research/Diagn. M&A, Partnerships

United States and Indonesia Expand Collaboration to End Tuberculosis

Jun 27, 2019 JAKARTA (June 27, 2019) — Today, the United States Government through the United States Agency for International Development (USAID) and BD (Becton, Dickinson and Company), a U.S.-based global medical technology company, formalized a new partnership to support Indonesia in eliminating tuberculosis (TB) through its National Tuberculosis Program. “Fighting TB with our Indonesian partners... Read more

June 26, 2019 Clinical Research/Diagn. Liq. Handling & Robotics M&A, Partnerships

Quanterix Announces Agreement to Acquire UmanDiagnostics, World’s Leading Neurofilament Light (Nf-L) Antibody Supplier

JUNE 26, 2019 Quanterix Announces Agreement to Acquire UmanDiagnostics, World’s Leading Neurofilament Light (Nf-L) Antibody Supplier Positions Quanterix to capitalize on significant growth opportunities with Nf-L applications in Alzheimer’s Disease, Multiple Sclerosis, and other neurodegenerative conditions Provides expected 200 bps of annualized company gross margin improvement, before impact of purchase price accounting, and expected to... Read more

June 20, 2019 Clinical Research/Diagn. PR/Corporate

Steven Daniel joins Cofactor Genomics as Vice President of Business Development

— Leading Cofactor’s commercial efforts to grow the Predictive Immune Modeling market   — San Francisco, June 20, 2019 (REPORTABLE) — Cofactor Genomics today announced the appointment of Steven Daniel, PhD as Vice President of Business Development, overseeing the development and execution of the company’s sales strategy and sales management. Dr. Daniel comes to Cofactor from... Read more

June 20, 2019 Clinical Research/Diagn.

QIAGEN Clinical Insight surpasses 1 million patient test cases analyzed and interpreted

Hilden, Germany, and Germantown, Maryland, June 20, 2019 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that QIAGEN Clinical Insight (QCI®), its clinical decision support platform for interpretation and reporting of variants derived from analysis of next-generation sequencing (NGS) data, has achieved a milestone of more than 1 million patient test cases analyzed... Read more

June 19, 2019 Clinical Research/Diagn. Liq. Handling & Robotics

QIAGEN and McKesson agree to distribute QIAstat-Dx syndromic testing solution to smaller hospitals and other select segments in the United States

Germantown, Maryland, and Hilden, Germany, June 19, 2019 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced an agreement for McKesson Medical-Surgical Inc., an affiliate of McKesson Corporation , a global leader in healthcare supply chain management solutions, to serve as the exclusive distributor of QIAGEN’s QIAstat-Dx syndromic testing solution in the “acute” market... Read more

June 19, 2019 Cell Analysis Tools Clinical Research/Diagn. Product Launch

Fluidigm Introduces Three Imaging Mass Cytometry Panel Kits and Advanced CyTOF Software to Accelerate Immuno-Oncology Research

PDF Version Illuminating the diversity of immune cell phenotypes and function in the context of the tumor microenvironment, all in a single scan SOUTH SAN FRANCISCO, Calif., June 19, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it... Read more

June 19, 2019 Clinical Research/Diagn. Lab Top-10 Life Science Tools M&A, Partnerships

Thermo Fisher Scientific and Predictive Laboratories Announce Global Infertility Research Collaboration

Thermo Fisher Scientific and Predictive Laboratories Announce Global Infertility Research Collaboration Studies aim to elucidate infertility genetics for development of noninvasive test to support decision making and improved outcomes for women pursuing fertility treatment CARLSBAD, Calif., June 19, 2019 /PRNewswire/ — Thermo Fisher Scientific announced today that it has entered into a global research collaboration... Read more

June 18, 2019 Clinical Research/Diagn. Life Science Tools Product Launch

QIAGEN to deliver genomic insights for Japan’s new molecular oncology clinical research and precision medicine initiative

Hilden, Germany, and Tokyo, Japan, June 18, 2019 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its QIAGEN Clinical Insight (QCI) offering was selected by the National Cancer Center of Japan, as part of the Japan’s Ministry of Health, Labour and Welfare’s precision medicine program, for the analysis, interpretation and reporting of molecular... Read more